Research-track resident
Psychiatry
Dr. Michael J. Gandal, MD
|
|
Give Review
Michael Gandal works in the field of Psychiatry. He went to Perelman School of Medicine at the University of Pennsylvania. Michael Gandal is also a published MD. He has 18 publication published. The most recent publication is: Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
Publications
- Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
- Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability.
- Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology.
- Parvalbumin Cell Ablation of NMDA-R1 Causes Increased Resting Network Excitability with Associated Social and Self-Care Deficits.
- Measuring the maturity of the fast-spiking interneuron transcriptional program in autism, schizophrenia, and bipolar disorder.
- NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders.
- Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density.
- NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia.
- MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.
- Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.
- Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.
- mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism.
- Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism.
- Mouse behavioral endophenotypes for schizophrenia.
- In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia.
- Ketamine modulates theta and gamma oscillations.
- Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.
Schools
Perelman School of Medicine University of Pennsylvania
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
UCLA Medical Center -
Perelman School of Medicine at the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Andrew Lee, MD |
|
|
Dr. Nancy L. Rosser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul N. Barkopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert T. Cobb, MD |
|
|
Dr. Robin L. Kissell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott A. Sweet, MD |
|
|
Dr. Howard D. Ross, MD |